Sierra Leone vs Switzerland: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Sierra Leone
93.0%
in 2025
Switzerland
92.0%
in 2025
Sierra Leone rank
53rd
Switzerland rank
56th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Sierra Leone
- Switzerland
How they compare
Sierra Leone currently reports 93.0% against 92.0% in Switzerland, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Switzerland ahead.
Sierra Leone ranks 53rd and Switzerland ranks 56th of 194 countries.
Across the 3 decades both report, Sierra Leone averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Sierra Leone | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 19.0% | 19.0% | Switzerland |
| 2010s | 78.8% | 71.6% | 7.2% | Sierra Leone |
| 2020s | 92.2% | 89.2% | 3.0% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Sierra Leone or Switzerland?
- Sierra Leone, at 93.0% against 92.0% in Switzerland as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Sierra Leone and Switzerland?
- 1.0%, with Sierra Leone ahead.
- How many years of comparable data are there for Sierra Leone and Switzerland?
- 18 years are reported by both, from 2008 to 2025.
- How do Sierra Leone and Switzerland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Sierra Leone ranks 53rd and Switzerland ranks 56th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.